Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Non-Tech : Bill Wexler's Trading Cabana -- Ignore unavailable to you. Want to Upgrade?

To: Kevin Podsiadlik who wrote (5397)	4/28/2009 10:14:39 AM
From: RockyBalboa	Read Replies (1) \| Respond to of 6370

77cents, well thats manageable. Actually the pops are invitations to size up. But thanks for the warning... oh, now 72c...tourists get off the bus.

To: Kevin Podsiadlik who wrote (5397)	5/11/2009 7:32:58 AM
From: RockyBalboa	Respond to of 6370

You called that right, a heavy pump of this. Stuff for 90% decline once done, FDA review is this month. Yahoo board is boiling over and treat it like the next VNDA. The stock still trades in homoeopathic quantities. I sold 30 shares at 1.95, thats approximately the price of todays dinner. That said, I often forget that speculative microcaps see such jumps in the latter phases of an aging bull. >>>>>>>>>>>>> Re: Will Ampligen ever be approved? 10-May-09 12:36 am The decision will out this week, due to the holiday recess. There will be a nashing and gashing of teeth at HEB as all it's employees were paid with worthless paper.....obviously a ploy by HEB to beg for mercy from the FDA. They get some mercy, but only in the form of advice and help